Deal eases fears of competition to GSK asthma drug
March 18, 2010 at 09:00 AM EDT
Concerns about competition for a key GlaxoSmithKline asthma drug were alleviated on Thursday, after the transfer of the U.S. development rights of a potential generic rival product.
